title: Single institution long-term efficacy and safety analysis of abiraterone acetate (AA) in the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) in a named patient programme (NPP).
authors.affiliation: Department of Oncology and Nuclear Medicine , University Hospital Center Sestre Milosrdnice , Zagreb , Croatia.
authors.forename: Ana
authors.initials: A
authors.lastname: Fröbe
authors.affiliation: Department of Oncology and Nuclear Medicine , University Hospital Center Sestre Milosrdnice , Zagreb , Croatia.
authors.forename: Jure
authors.initials: J
authors.lastname: Murgić
authors.affiliation: Hospital Center Emile Mayrisch , Esch-sur-Alzette , Luxemburg.
authors.forename: Stefan
authors.initials: S
authors.lastname: Rauh
keywords: long term hormone therapy efficacy; metastatic castration-resistant prostate cancer (mCRPC)